Family-Based Treatment for Type 1 Diabetes
FBT for T1D
A Family-Based Approach to Treat Obesity and Its Co-morbidities in Youth With Type 1 Diabetes (T1D) and Their Parents
2 other identifiers
interventional
20
1 country
1
Brief Summary
Type 1 Diabetes carries high burden for affected youth and their families. Advances in insulin therapy and technology have been associated with increased obesity with 1/3 adolescents being overweight/obese. Since obesity runs in families and carries risk for poor outcomes psychologically and medically, the investigators are adapting our successful evidence-based Family Based Treatment for hybrid delivery to improve obesity and metabolic control in the affected youth and improve obesity and related co-morbidities in their parents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 9, 2023
CompletedFirst Posted
Study publicly available on registry
March 6, 2023
CompletedStudy Start
First participant enrolled
April 26, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedSeptember 16, 2025
September 1, 2025
2.2 years
February 9, 2023
September 9, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Weight for parent and child
Participants will be given Body Trace Weight Scales and will weigh themselves twice per week.
Baseline, 3 and 6 months
Secondary Outcomes (5)
Change in insulin dosing
baseline, 3 and 6 months
In parents, change in severity of obesity co-morbidities
baseline, 3 and 6 months
Change in HbA1c
baseline, 3 and 6 months
Change in time in range (TIR) - that is in optimal glycemic range
baseline, 3 and 6 months
In parents, change in medication dosing
baseline, 3 and 6 months
Study Arms (1)
20 Child-Parent Dyads
EXPERIMENTALFamily-Based Behavioral Treatment
Interventions
Our FBT curriculum, which has been delivered successfully in the specialty and primary care settings, has 3 components: 1. Meal planning including quality of carbohydrates and glycemic index for both parents and children while ensuring that youth have a balanced meal plan with adequate amounts of carbohydrates for optimal growth. Our FBT has a focus on "Food Literacy" including healthy food selection and sourcing of affordable healthy food, food preparation and preplanning, social engagement tailoring the meal plan to the needs to the family in socio cultural appropriate way and also feasibility based on logistics and economic aspects; 2. Physical activity (PA) component with shaping strategy to allow for a progressive shaping of easy PA starting, if needed, with as little as with 10 minutes of walking/day and strategies to incorporate PA in daily routines, family, and social activities; 3. Extensive behavioral component which has been shown to be very powerful in obesity treatment
Eligibility Criteria
You may qualify if:
- T1D of 12 or more months duration
- Age 6-17-years
- Presence of overweight/obesity
- Youth uses a pump for insulin delivery and a continuous glucose monitoring device to monitor glycemic levels
- Youth has one parent with overweight/obesity willing to participate in the program
You may not qualify if:
- Child:
- Chronic conditions other than T1D
- Other autoimmune conditions other then T1D or autoimmune thyroiditis.
- Medications that can affects weight, such as medications used to treat Attention Deficit Disorder or high dose steroids used to treat asthma.
- Depression symptoms by standard of care Patient Health Questionnaire (PHQ) 9 in the child or parent
- Inability to perform at least mild physical activity such as walking
- Child with handicap (such as developmental delay or deafness) that would prevent him/her from benefitting from counseling in person and/or remotely Participating parent with
- symptoms of depression assessed by standard of care PHQ
- autoimmune disorders other than T1D or autoimmune thyroiditis
- Participating parents with chronic disorder that is treated with medications that interfere with weight loss or are preventing him/her from performing at least mild physical activity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Conventus
Buffalo, New York, 14203, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 9, 2023
First Posted
March 6, 2023
Study Start
April 26, 2023
Primary Completion
July 7, 2025
Study Completion (Estimated)
December 31, 2026
Last Updated
September 16, 2025
Record last verified: 2025-09